JRNYS materials reference compounded semaglutide and compounded tirzepatide as options that may be discussed when clinically appropriate and legally available
For very long trips, consider whether you can arrange prescription transfers or refills at your destination
Most patients begin noticing changes within the first month
Activated charcoal supplements bind hydrogen sulfide gas, though evidence for their effectiveness remains mixedsome users report relief while others see no change
Several licensed options are currently available in the UK, including semaglutide 2.4 mg (Wegovy), tirzepatide (Mounjaro), orlistat, liraglutide 3 mg (Saxenda), and naltrexone/bupropion (Mysimba)
Precautions and Contraindications While generally well-tolerated, GLP-1 agonists are not recommended for certain patient populations or medical conditions